Rheumatoid Arthritis Completed Phase 4 Trials for Methylprednisolone (DB00959)

Also known as: RA / Rheumatic Arthritis / Arthritis, Rheumatoid / Arthritis,Rheumatoid / Rheumatoid Arthritis (RA) / Rheumatoid Arthritis(RA) / Arthritis, Rheumatoid (RA) / Systemic rheumatoid arthritis / Arthritis rheumatoid / Rheumatoid arthritis, unspecified / R arthritis / Rh arthritis / Atrophic arthritis

IndicationStatusPhase
DBCOND0027961 (Rheumatoid Arthritis)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01308255Infliximab as Induction Therapy in Early Rheumatoid Arthritis (IDEA)Treatment
NCT00396747A Comparison of Methotrexate Alone or Combined to Infliximab or to Pulse Methylprednisolone in Early Rheumatoid Arthritis: A Magnetic Resonance Imaging StudyTreatment
NCT01219933A Study of Glucocorticoid Use to Evaluate Systematic Methylprednisolone Reduction in Patients With Rheumatoid Arthritis on Background RoActemra/Actemra (Tocilizumab) (ACT-ALONE)Treatment
NCT01382940A Study on The Safety of Administering Rituximab at A More Rapid Rate in Patients With Rheumatoid ArthritisTreatment
NCT01000610A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and an Inadequate Response to MethotrexateTreatment